J Y Ro
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 3
- Oncology top 10%
- Cancer-related Molecular Pathways 4
- Cancer Research top 10%
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Periodontics top 5%
-
- Cancer Research and Treatments 2
-
- Oral and Maxillofacial Pathology 2
-
- Antifungal resistance and susceptibility 1
-
- Bladder and Urothelial Cancer Treatments 1
J Y Ro
17 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 67
- Otorhinolaryngology 133
- Oncology 427
- Cancer Research 189
- Molecular Biology 729
- Periodontics 49
Countries citing papers authored by J Y Ro
This map shows the geographic impact of J Y Ro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Y Ro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Y Ro more than expected).
Fields of papers citing papers by J Y Ro
This network shows the impact of papers produced by J Y Ro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Y Ro. The network helps show where J Y Ro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J Y Ro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CpG island methylation in premalignant stages of gastric carcinoma. | 2001 | 257 |
| 2 | 2000 | 121 | |
| 3 | 2000 | 19 | |
| 4 | Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. | 1998 | 43 |
| 5 | 1996 | 67 | |
| 6 | Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer. | 1996 | 2 |
| 7 | 1995 | 133 | |
| 8 | Methods in pathology. Optimization of proliferating cell nuclear antigen immunohistochemical staining by microwave heating in zinc sulfate solution. | 1994 | 6 |
| 9 | 1994 | 19 | |
| 10 | Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. | 1994 | 187 |
| 11 | 1993 | 48 | |
| 12 | Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. | 1993 | 110 |
| 13 | 1992 | 60 | |
| 14 | 1992 | 195 | |
| 15 | Transitional mucosa of colon. A morphological, histochemical, and immunohistochemical study. | 1990 | 11 |
| 16 | SIS/PDGF-B expression in benign and malignant human breast lesions. | 1989 | 18 |
| 17 | Yellow-brown (Hamazaki-Wesenberg) bodies mimicking fungal yeasts. | 1987 | 12 |
About J Y Ro
J Y Ro is a scholar working on Microbiology, Otorhinolaryngology and Oral Surgery, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Head and Neck Cancer Studies (3 papers), Cancer Research and Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), Oral and Maxillofacial Pathology (2 papers), RNA modifications and cancer (2 papers), Antifungal resistance and susceptibility (1 paper) and Bladder and Urothelial Cancer Treatments (1 paper). The work is most often cited by research in Otorhinolaryngology (133 citations), Oncology (427 citations) and Cancer Research (189 citations). J Y Ro has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include Gyeong Hoon Kang, Dong M. Shin, Hwoon‐Yong Jung, Woo Ho Kim, Reuben Lotan, Nelson G. Ordóǹez, W K Hong, A. Şahin, C. Logothetis and William F. Benedict. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer, Journal of Clinical Oncology, Oncology Reports and International Journal of Gynecological Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.